Having begun sales in late 2019, Weekend branded products are now in over 75 dispensaries in the state and expanding presence daily. Oklahoma was identified as an up and coming market, a focus for the Company’s strategic plan – to develop products to meet the demands within individual markets, establish a foothold and operate in an agile manner with the best partners, creating the right branded product mix for each market. Ultimately, the Company is designed to leverage the core branded products to expand into up and coming states and to replicate the responsive model. In Oklahoma Weekend has added two highly experienced cannabis sales representatives to its team to manage and grow the Company’s expanding retail relationship network.
“Oklahoma is proving to be an ideal growth market for Weekend’s branded products,” said Mr. Chris Backus, Weekend President and CEO. “Our partnership with Ruby Mae’s is becoming stronger by the day, from branded product development through to sales, distribution and retail dispensary presence in Oklahoma represents the ideal model for replication in other up and coming states in the future. We have expanded the WKND! branded product line, now up to 11 SKU’s, with the latest additions of a dark chocolate almond bar and caramel chews. Based on the success we are preparing to launch our next brand, Orchard Heights branded products, into the Oklahoma market.”
Oklahoma Market Advancements
- Weekend branded product line grows to 11 SKU’s, including latest additions of:
I. Dark Chocolate Almond Bar; 8 pieces @ 25 mg THC each; 200 mg total
II. Escape Caramel Chews; 5 caramels @ 50 mg THC each; 250 mg total
- Orchard Heights branded product line preparing for launch in Oklahoma
- Additions of Oklahoma Cannabis Sales representatives Brady Watson and Brianna Carey:
- Brady Watson – Oklahoma cannabis market production and sales expert has played a leadership role with Ruby Mae’s since inception, and is a US Veteran with a statewide retail network which will accelerate Weekend’s reach immediately
- Brianna Carey – a leader in the Oklahoma cannabis industry since the Medical Marijuana program was legalized in 2018, bringing extensive product and marketplace knowledge, only matched by her relationships throughout the state.
The management team has tuned into the needs of consumers in the market in the development of the branded product line, where there is demand for high quality products with high levels of THC, in order to grow consumer loyalty and increase revenues. Weekend has developed an efficient model to work with local partners, developing an agile capability to turn good product ideas into real products and get them on the market to meet consumer demand.
The Orchard Heights branded product line, featuring vape cartridges and rosin items, is being positioned as a mid-market brand to generate higher volumes. “Orchard Heights will feature solvent free concentrates to market, including Flower Rosin, Kief Rosin, Hash Rosin, & Live Rosin. “We’ve identified a need in the market for these products and have developed and produced them, utilizing the best equipment available and a completely solvent free process,” said Mr. Backus.
For further information, please contact:
Mr. Chris Backus, President & CEO, Director
Telephone: 1(236) 317-2812
About Weekend Unlimited Industries Inc.
Weekend Unlimited is a lifestyle-based recreational cannabis and CBD wellness company. We are developing and launching premium cannabis and CBD brands to deliver life’s highs – any- time, anywhere. Our CBD products are available online and at a retailer near you. Weekend Unlimited is well-positioned to launch and scale the brands that will define cannabis and
CBD. Learn more at www.weekendunlimited.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the poli- cies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward- looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking infor- mation reflects management’s current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “predicts”, “intends”, “targets”, “aims”, “anticipates” or “believes” or variations (including negative variations) of such words and phrases or may be identified by state- ments to the effect that certain actions “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward- looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic condi- tions, industry conditions and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new in- formation, future events, or otherwise, except as required by securities laws.
Agreement propels development of safe and effective proprietary products and formulations for the emerging psychedelic industry
Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that effective January 4, 2021, it entered into a lab services agreement with Numinus Wellness Inc. (“Numinus“). Recognized as an early leader in developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies (PAP), Numinus is aiding Optimi’s mission to further the research and development of Canadian-grown psilocybin-producing mushrooms and related product formulations.
Nextleaf Solutions Provides a Corporate Update and Comments on Financial Results from the First Quarter
Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis processor, is pleased to provide shareholders with the following corporate update:
Nextleaf Comments on Financial Results from Q1 Financials
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”) reported its second quarter results for the period ended December 31, 2020. A complete set of financial statements and Management’s Discussion & Analysis has been filed at www.sedar.com. All dollar figures are quoted in Canadian dollars.
The second quarter of FY21, saw continued momentum for the Company despite ongoing pandemic related challenges. Net revenue grew 8% to $745,748 from $689,276 versus the same quarter year ago. The Company also saw significant improvement on its bottom line, reducing its net loss by 50% from ($.956) million to ($.481) million, year over year for the quarter, as a result of improved gross margin and cost management efforts. On December 9, 2020, the company announced the closing of the acquisition of substantially all of the assets of Lexaria Canpharm (“Canpharm“), the cannabis products division of Lexaria Biosciences, resulting in the addition of a new B2B Line of Business.
FinCanna Capital – The Only Publicly Traded, Royalty-Focused Company for the Licensed U.S. Cannabis Industry Provides Corporate Update
Royalty Model Provides Access to Early Stage Licenced U.S. Cannabis Companies and Leverage to High-Margin Revenues
FinCanna Capital Corp. (“FinCanna” or the “Company”) (CSE:CALI), a royalty company for the licensed U.S. cannabis industry, is pleased to provide a corporate update further to its recently announced upsized financing of $2 million
Significant progress made as Numinus-sponsored PRIME study on psilocybin-assisted psychotherapy for opioid, stimulant and/or alcohol use disorders enters pre-implementation stage
Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies (PAP), and Syreon Corporation (Syreon), a global contract research organization with expertise in conducting clinical trials across a broad range of diseases, are pleased to share that significant progress has been made in the single-arm, open-label compassionate access 1 trial of Psilocybin-Research Intervention with Motivational Enhancement (PRIME) for substance use disorders. Currently in the development stage, the PRIME study will assess the efficacy and safety of psilocybin-assisted motivational enhancement therapy.